跳至主要内容
临床试验/NCT03414320
NCT03414320已完成不适用

Proof of Concept Study for the Identification of Patient-specific Parameters for Bolus Calculators in Type 1 Diabetic Patients

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2018年1月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
1
主要终点
Accepting mathematical model

研究概览

简要总结

The adoption of bolus calculators has been limited by the slow speed of the current trial and error approach. The goal of this project is to automate the determination of patient specific insulin pump parameters based on current automatic electronic logbooks of glucose measurements, carbohydrate intake, and insulin usage, by means of a mathematical model. More specifically, the investigators are interested in computing the carbohydrate to insulin ratio (CIR) and insulin sensitivity factor (ISF), which are the main parameters of bolus calculators.

The present study is a proof-of-concept, open label, single arm clinical trial to validate the new method and refine both the mathematical model and the numerical techniques in well-regulated and disciplined type 1 diabetic subject.

The study is a "trial" of the selected underlying mathematical model and the associated algorithms to simulate the glucose values of a patient with uncertain meal-data.

详细描述

After signing informed consent and checking eligibility criteria participants will receive uniform education related to self-monitoring of blood glucose and continuous glucose monitoring (CGM) using the CGM sensor as well as on the bolus calculator (BC). The study will take three weeks (or three sensors) per patient.

Patients should live a close to normal life and should participate in their normal daily activities. During the study, patients must consequently keep using the BC of their insulin pump, record in the insulin pump when they eat extra food outside their regular meals and when they inject extra insulin without the use of their insulin pump. Faulty 'meal markers' have to be noted in a booklet and patients will also have to take pictures of their plate for each meal or record their meals in detail in a booklet. Patients should also consequently shut off insulin delivery when they disconnect their insulin pump and write it down in a booklet. The patients will be asked to wear an activity tracker (i.e. Fitbit), this data will help in the refinement of the model and will be used for research later in the same project.

During the study, patients must skip a total of three meals: breakfast, lunch and dinner (not on the same day, but within the three weeks). This gives the investigators a period of measurements in which they know that there are no significant amounts of unpredictable carbohydrates in the blood. Patients can give correction insulin or take extra fast carbohydrates to correct the glycaemia when needed and record this in the insulin pump or in a booklet. The fast rescue carbohydrates should be in the form of Dextro energy tablets (provided by the study team).

After the three weeks, patients will come back to the hospital where the study team will download data from the insulin pump, CGM sensor, and activity tracker. The booklet and photographs of the meals will be handed over to the study team. This is the end of the study for the patient. The collected patient data will further be used to assess the model fit of the chosen mathematical model as in, i.e. the investigators evaluate how well the model is able to reproduce the collected data.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Signed informed consent
  • •Patient followed at the endocrinology department of UZ Leuven
  • •Type 1 diabetes
  • •Treated with subcutaneous insulin pump (CSII) for more than 12 weeks
  • •Using a continuous glucose monitor (CGM) for more than 12 weeks
  • •No known diabetic gastroparesis
  • •C-peptide negative
  • •HbA1c between 6-10%
  • •Using, or willing to use, the bolus calculator

排除标准

  • •Type 2 diabetes, patients with secondary diabetes
  • •Patients treated with multiple daily insulin injections or begin of treatment with CSII less than 12 weeks before inclusion
  • •Known diabetic gastroparesis
  • •C-peptide positive
  • •HbA1c < 6% or > 10%
  • •Not using or not willing to use the bolus calculator

研究组 & 干预措施

Study Arm

Experimental

We will gather data from this group of patients.

干预措施: Gathering data (Other)

结局指标

主要结局

Accepting mathematical model

时间窗: three weeks

The primary outcome measure will be to accept or reject the mathematical model by calculating mean-squared error differences with the data.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

prof dr Pieter Gillard

Principal Investigator

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验